Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cell-Free Blood Cell Secretome (BCS) Counteracts Skin Aging: Multi-Center Prospective Regenerative Aesthetic Medicine Study Using Exokine®.
Kerscher M, Wagner-Schiffler S, Noah EM, Fischer T, Greiner-Krüger D, Sattler S, Kaptan T, Drabik A, Hamed G, Reinecke J, Wehling J. Kerscher M, et al. Among authors: noah em. Clin Cosmet Investig Dermatol. 2022 Jun 27;15:1157-1173. doi: 10.2147/CCID.S357810. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35784268 Free PMC article. Clinical Trial.
Corrigendum to: Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P. Ascher B, et al. Among authors: noah em. Aesthet Surg J. 2021 Oct 15;41(11):1338. doi: 10.1093/asj/sjab111. Aesthet Surg J. 2021. PMID: 33739363 Free PMC article. No abstract available.
Safety and Performance of Etermis 3 and 4 in Wrinkles/Folds Treatment and Facial Volume Enhancement: A Prospective, Evaluator-Blinded, Open-Label Study.
Sattler G, Kerscher M, Noah EM, Prager W, Fischer TC, Ogilvie P, Hofmann M, Dersch H, Odena G. Sattler G, et al. Among authors: noah em. Clin Cosmet Investig Dermatol. 2020 Aug 19;13:591-599. doi: 10.2147/CCID.S244598. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 32884321 Free PMC article.
Significantly Increased Patient Satisfaction Following Liquid Formulation AbobotulinumtoxinA Treatment in Glabellar Lines: FACE-Q Outcomes From a Phase 3 Clinical Trial.
Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P. Ascher B, et al. Among authors: noah em. Aesthet Surg J. 2020 Aug 14;40(9):1000-1008. doi: 10.1093/asj/sjz248. Aesthet Surg J. 2020. PMID: 31550352 Free PMC article. Clinical Trial.
Liquid Formulation of AbobotulinumtoxinA: A 6-Month, Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of a Single Treatment, Ready-to-Use Toxin for Moderate-to-Severe Glabellar Lines.
Ascher B, Rzany B, Kestemont P, Hilton S, Heckmann M, Bodokh I, Noah EM, Boineau D, Kerscher M, Volteau M, Le Berre P, Picaut P. Ascher B, et al. Among authors: noah em. Aesthet Surg J. 2020 Jan 1;40(1):93-104. doi: 10.1093/asj/sjz003. Aesthet Surg J. 2020. PMID: 30893430 Free PMC article. Clinical Trial.
58 results